Microbiome Sequencing Services Market Research and Forecast Report 2022-2027

1. Global Microbiome Sequencing Services Market Research and Forecast Report 2022-2027 Author: Elena Anderson Marketing Manager Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2022 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Microbiome Sequencing Services Market Research Report 2022-2027: According to the latest report by IMARC Group, titled “Microbiome Sequencing Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global microbiome sequencing services market reached a value of US$ 1,537.3 Million in 2021. Microbiome sequencing services assist in evaluating microflora in human biota to understand the function of microbes in human health and disease pathogenesis. They utilize next-generation sequencing (NGS) technologies to analyze microorganisms growing on saliva, oral mucosa, skin, conjunctiva, and gastrointestinal tract. Microbiome sequencing services are widely utilized for disease diagnosis and determining a patient’s response to a specific treatment. As compared to conventional microbiology methods, microbiome sequencing is more cost-effective, less labor-intensive, saves time, and provides faster and more accurate classifications. It is also capable of identifying low-abundant bacteria, characterizing non-cultivable bacteria, and profiling numerous microorganisms in a single analysis. Request for a PDF sample of this report: https://www.imarcgroup.com/microbiome-sequencing- services-market/requestsample

4. Report Description and Highlights Report Description Global Microbiome Sequencing Services Market Trends: The rising consumer awareness about the advantages of early diagnosis and disease detection is one of the key factors driving the market growth. Microbiome sequencing services are widely used to understand the relationship between human pathogen and gut microbiome that assist in determining the health status and diagnosing infectious, inflammatory, immune, and obesity-related diseases. In addition, the rising prevalence of colorectal cancer (CRC) on account of the increasing geriatric population, proliferation of inflammatory intestinal conditions, and widespread consumption of low fiber and high-fat diet is acting as another growth-inducing factor. Furthermore, recent technological advancements in NGS, such as the introduction of nanopore sequencing technology and single-molecule real-time sequencing (SMRT) methods that enhance data yield, reduce amplification bias, and minimize costs, are providing a considerable boost to the market growth. Additionally, the integration of machine learning (ML) and artificial intelligence (AI) to interpret enormous microbiome data for improving diagnostic accuracy and predicting diseases is creating a positive outlook for the market. Moreover, the significant growth in the pharmaceutical industry and the increasing need to study drug- microbiome interaction for developing novel drugs, personalized medicines, and biomarkers are providing an impetus to the market growth.

5. Report Description and Highlights Report Description Other factors, including increasing investments in microbiome research, the significant development in the healthcare industry, and the rising service adoption in academia and research institutes for small molecule and protein analysis, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 4,612.0 Million by 2027, exhibiting a CAGR of 20.2% during 2022-2027. View Report TOC, Figures and Tables: https://www.imarcgroup.com/microbiome-sequencing- services-market

6. Report Description and Highlights Report Description Key Market Segmentation The research report includes the following segments: Breakup by Technology: •Sequencing by Synthesis (SBS) •Sequencing by Ligation (SBL) •Pyrosequencing •Sanger Sequencing •Others Breakup by Research Type: •Outsourced Research •Internal Research Breakup by Application: •Shotgun Sequencing •Targeted Gene Sequencing •RNA Sequencing •Whole Genome Sequencing •Others

7. Report Description and Highlights Report Description Breakup by Laboratory Type: •Dry Labs •Wet Labs Breakup by End User: •Pharmaceutical and Biotechnology Companies •Research and Academic Institutes •Others Breakup by Region: •North America •Asia Pacific •Europe •Latin America •Middle East and Africa

8. Report Description and Highlights Report Description Competitive Landscape with Key Players: •BaseClear B.V. •Clinical-Microbiomics A/S •Diversigen Inc (OraSure Technologies Inc.) •Mérieux NutriSciences •Metabiomics Corporation (BioSpherex LLC) •Microbiome Insights Inc. •Microbiome Therapeutics LLC •Molecular Research LP •Molzym GmbH & Co. KG •Resphera Biosciences LLC •Shanghai Realbio Technology (RBT) Co. Ltd. •Zymo Research Corporation.

9. Key Questions Answered in the Report Report Description 1. How has the global microbiome sequencing services market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global microbiome sequencing services market? What are the key regional markets? What is the breakup of the market based on the technology? What is the breakup of the market based on the research type? What is the breakup of the market based on the laboratory type? What is the breakup of the market based on the application? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? 10. What are the key driving factors and challenges in the industry? 11. What is the structure of the global microbiome sequencing services market and who are the key players? 12. What is the degree of competition in the industry? 2. 3. 4. 5. 6. 7. 8. 9.

10. Report DescriptionTable of Contents 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Microbiome Sequencing Services Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast

11. Report DescriptionTable of Contents 6 Market Breakup by Technology 6.1 Sequencing by Synthesis (SBS) 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Sequencing by Ligation (SBL) 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Pyrosequencing 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Sanger Sequencing 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Others 6.5.1 Market Trends 6.5.2 Market Forecast 7 Market Breakup by Research Type Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/microbiome-sequencing-services-market/toc

12. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

13. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

14. Report Description and Highlights Report Description © 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

15. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com